The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example

The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example

Osteoarthritis (OA) is a degenerative joint disease with a substantial global burden, causing chronic pain and reduced quality of life. Managing OA efficiently while maximizing healthcare resources is crucial. Health economics and health technology assessment (HTA) are central tools providing a fram...

Full description

Bibliographic Details
Main Authors:	Mickaël Hiligsmann, Olivier Bruyère
Format:	Article
Language:	English
Published:	AboutScience Srl 2024-04-01
Series:	Global & Regional Health Technology Assessment
Subjects:	Cost-effectiveness Economic evaluation Health technology assessment (HTA) Osteoarthritis (OA) Quality-adjusted life years (QALY)
Online Access:	https://journals.aboutscience.eu/index.php/grhta/article/view/2682

Similar Items

HTA – Algorithm or Process?; Comment on “Expanded HTA: Enhancing Fairness and Legitimacy”
by: Anthony J. Culyer
Published: (2016-08-01)

Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
by: Federico Augustovski, et al.
Published: (2018-02-01)

Cost-effectiveness analysis of sarcopenia management interventions in Iran
by: Ali Darvishi, et al.
Published: (2023-05-01)

Valuing infertility treatment: Why QALYs are inadequate, and an alternative approach to cost-effectiveness thresholds
by: Elena Keller, et al.
Published: (2022-12-01)

Pharmacoeconomic analysis of the use of tocilizumab in therapy for rheumatoid arthritis:imitation simulation
by: Dmitry Vladimirovich Goryachev, et al.
Published: (2010-04-01)

Cost–Utility Analysis of Wide-Field Imaging as an Auxiliary Technology for Retinopathy of Prematurity Care in Brazil
by: Luiza M Neves, et al.
Published: (2021-12-01)

Considering the societal perspective in economic evaluations: a systematic review in the case of depression
by: Juliane Andrea Duevel, et al.
Published: (2020-09-01)

The application of the QALY measure in the assessment of the effects of health interventions on an older population: a systematic scoping review
by: Ewa Kocot, et al.
Published: (2021-11-01)

Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review
by: Balijepalli C, et al.
Published: (2020-08-01)

Using Managed Entry Agreements as an Effective Tool to Handle the Uncertainty in Health Technology Assessments
by: Vatsal Chhaya, et al.
Published: (2022-07-01)

Cooled radiofrequency ablation of the genicular nerves for chronic pain due to osteoarthritis of the knee: a cost-effectiveness analysis compared with intra-articular hyaluronan injections based on trial data
by: Mehul J. Desai, et al.
Published: (2022-05-01)

THE USE OF QALY AS AN INTEGRAL MEASURE OF EFFECTIVENESS IN THE EVALUATION OF MEDICAL TECHNOLOGIES
by: N. Z. Musina, et al.
Published: (2017-05-01)

Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab
by: Yifan Xu, et al.
Published: (2018-11-01)

The integrated care pathway for managing post stroke patients (iCaPPS©) in public primary care Healthcentres in Malaysia: impact on quality adjusted life years (QALYs) and cost effectiveness analysis
by: Aznida Firzah Abdul Aziz, et al.
Published: (2020-02-01)

Cost-Effectiveness of In-House Versus Contracted-Out Vision Rehabilitation Services in England
by: Francesco Longo, et al.
Published: (2020-09-01)

Cost-Effectiveness of In-House Versus Contracted-Out Vision Rehabilitation Services in England
by: Francesco Longo, et al.
Published: (2020-09-01)

Economic evaluations of 13-valent pneumococcal conjugate vaccine: a systematic review
by: Yuanze Du, et al.
Published: (2023-12-01)

Development of a balanced instrument to measure global health-related quality of life: The 13-MD
by: Moustapha Touré, et al.
Published: (2022-09-01)

Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system
by: T. S. Teptsova, et al.
Published: (2021-02-01)

Commentary: Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared With Aspirin Alone in Patients With Coronary and Peripheral Artery Diseases in Italy
by: Shalin Rawal, et al.
Published: (2022-06-01)

Septoplasty versus non-surgical management for nasal obstruction in adults with a deviated septum: economic evaluation alongside a randomized controlled trial
by: M. M. H. T. van Egmond, et al.
Published: (2020-05-01)

The economic consequences of attention-deficit hyperactivity disorder in the Scottish prison system
by: Susan Young, et al.
Published: (2018-06-01)

The Regional Burden and Disability-Adjusted Life Years of Knee Osteoarthritis in Kazakhstan 2014–2020
by: Gulnur Zhakhina, et al.
Published: (2023-01-01)

Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients
by: Wenqian Li, et al.
Published: (2022-05-01)

Osteoarthritis as an Umbrella Term for Different Subsets of Humans Undergoing Joint Degeneration: The Need to Address the Differences to Develop Effective Conservative Treatments and Prevention Strategies
by: David A. Hart
Published: (2022-12-01)

Comparison of early-stage changes of osteoarthritis in cartilage and subchondral bone between two different rat models
by: Yutao Yang, et al.
Published: (2020-04-01)

Preference heterogeneity in health valuation: a latent class analysis of the Peru EQ-5D-5L values
by: Suzana Karim, et al.
Published: (2023-01-01)

Economic evaluation of routine infant rotavirus immunisation program in Japan
by: Shu-ling Hoshi, et al.
Published: (2017-05-01)

Extracorporeal carbon dioxide removal compared to ventilation alone in patients with acute hypoxaemic respiratory failure: cost-utility analysis of the REST RCT
by: Agus Ashley, et al.
Published: (2023-08-01)

Health technology assessment (HTA) and economic evaluation: efficiency or fairness first
by: Jeff Richardson, et al.
Published: (2019-01-01)

Economic burden on stroke survivors in Asian and African countries: A protocol for systematic review, meta-analysis, and meta-regression
by: Summaiya Zareen Shaikh, et al.
Published: (2023-01-01)

Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery
by: Krog AH, et al.
Published: (2017-06-01)

The association between vitamin K and medial tibial-femoral knee osteoarthritis progression: Data from the osteoarthritis initiative
by: Reuben William Horace, et al.
Published: (2021-09-01)

The Primary Process and Key Concepts of Economic Evaluation in Healthcare
by: Younhee Kim, et al.
Published: (2022-09-01)

Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study
by: Ming Fu, et al.
Published: (2022-01-01)

Are intersectoral costs considered in economic evaluations of interventions relating to sexually transmitted infections (STIs)? A systematic review
by: Lena Schnitzler, et al.
Published: (2022-11-01)

OSTEOARTHRITIS AND AGEING
by: Ana M. Valdes, et al.
Published: (2018-03-01)

Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model
by: Ming-Chin Yang, et al.
Published: (2017-01-01)

Burden of disease and economic evaluation of healthcare interventions: are we investigating what really matters?
by: Gènova-Maleras Ricard, et al.
Published: (2011-04-01)

Health Technology Assessment Process for Oncology Drugs: Impact of CADTH Changes on Public Payer Reimbursement Recommendations
by: Louise Binder, et al.
Published: (2022-03-01)